Acute myocardial infarction (AMI) has been a preclinical and clinical concern due to high hospitalization rate and mortality. This study was aimed at evaluating the effectiveness and safety of Shexiang Baoxin Pill (SBP) for AMI and exploring the possible mechanism of oxidative stress. Six databases were searched on March 26, 2021. Twenty-four studies were included and accessed by the RoB 2.0 or SYRCLE tool. Compared with routine treatment (RT), SBP showed the effectiveness in the clinical efficacy ( , 95% CI [1.06, 1.25]), left ventricular ejection fraction (LVEF) ( , 95% CI [0.62, 0.95]), glutathione (GSH) ( , 95% CI [1.51, 2.64]), superoxide dismutase (SOD) ( , 95% CI [0.58, 1.26]), malondialdehyde (MDA) ( , 95% CI [-5.80, -2.66]), creatine kinase-myocardial band (CK-MB) ( , 95% CI [-5.64, -4.33]), cardiac troponin I (cTnI) ( , 95% CI [-2.57, -1.76]), high-sensitivity C-reactive protein (Hs-CRP) ( , 95% CI [-1.56, -1.12]), interleukin-6 (IL-6) ( , 95% CI [-1.26, -0.71]), triglycerides (TG) ( , 95% CI [-0.83, -0.22]), flow-mediated dilation (FMD) ( , 95% CI [1.06, 1.72]), von Willebrand Factor (vWF) ( , 95% CI [-2.39, -1.15]), nitric oxide (NO) ( , 95% CI [0.65, 1.13]), and recurrent rate (
28 April 2021 in Evidence-Based Complementary and Alternative Medicine
Although traditional Chinese medicine is effective and safe for the treatment of angiogenesis, the in vivo intervention mechanism is diverse, complex, and largely unknown. Therefore, we aimed to explore the active ingredients of traditional Chinese medicine and their mechanisms of action against angiogenesis. Data on angiogenesis-related targets were collected from GeneCards, Therapeutic Target Database, Online Mendelian Inheritance in Man, DrugBank, and DisGeNET. These were matched to related molecular compounds and ingredients in the traditional Chinese medicine system pharmacology platform. The data were integrated and based on the condition of degree > 1, and relevant literature, target-compound, compound-medicine, and target-compound-medicine networks were constructed using Cytoscape. Molecular docking was used to predict the predominant binding combination of core targets and components. We obtained 79 targets for angiogenesis; 41 targets were matched to 3839 compounds, of which 110 compounds were selected owing to their high correlation with angiogenesis. Fifty-five combinations in the network were obtained by molecular docking, among which PTGS2-astragalin (9.18kcal/mol), KDR-astragalin (7.94kcal/mol), PTGS2-quercetin (7.41kcal/mol), and PTGS2-myricetin (7.21kcal/mol) were top. These results indicated that the selected potential core compounds have good binding activity with the core targets. Eighty new combinations were obtained from the network, and the top combinations based on affinity were KDR-beta-carotene (10.13kcal/mol), MMP9-beta-sitosterol (8.04kcal/mol), MMP9-astragalin (7.82kcal/mol), and MMP9-diosgenin (7.51kcal/mol). The core targets included PTGS2, KDR, VEGFA, and MMP9. The essential components identified were astragalin, kaempferol, myricetin, quercetin, and β-sitosterol. The crucial Chinese medicines identified included Polygoni Cuspidati Rhizoma et Radix, Morus alba Root Bark, and Forsythiae Fructus. By systematically analysing the ingredients of traditional Chinese medicine and their targets, it is possible to determine their potential mechanisms of action against pathological angiogenesis. Our study provides a basis for further research and the development of new therapeutics for angiogenesis.
29 April 2021 in Evidence-Based Complementary and Alternative Medicine
A peptic ulcer (PU) is a digestive disorder most commonly found in clinical practice. An oriental herbal formula, Xiao Chai Hu Tang (XCHT), has been used to treat PU for an extended period in China. The effectiveness and safety of XCHT in treating peptic ulcers was evaluated using a systematic review of randomized controlled trials (RCTs). Studies were systematically retrieved from CNKI, Embase, Medline, PubMed, SinoMed, VIP, Wanfang, and Web of Science. The following information was extracted from the relevant RCTs: the clinical efficacy rate, recurrence rate, clinical efficacy of traditional Chinese medicine, and the adverse effects. 13 RCTs, including 1334 patients, were included in this review. The meta-analysis showed that treatment with XCHT was superior to conventional pharmacotherapy (CPT) in improving the clinical efficacy rate (RR: 1.20, 95% confidence intervals (CIs): 1.08–1.34, ), poor appetite (RR: 0.30, 95% CI: 0.15–0.61, ), abdominal distension (RR: 0.61, 95% CI: 0.39–0.96, ), vomiting (RR: 0.33, 95% CI: 0.19–0.55, ), and stomach pain (RR: 0.36, 95% CI: 0.19–0.68, ) and reducing adverse events (RR: 0.23, 95% CI: 0.07–0.69, ). XCHT considerably increased the total clinical efficacy rate (RR: 1.22, 95% CI: 1.15–1.30, ) as both monotherapy and adjunctive therapy. The recurrence rate (RR = 0.29; 95% CI: 0.16–0.52, ) was remarkably decreased in the XCHT plus CPT group. The meta-analysis did not show a significant beneficial effect of XCHT compared with CPT in reducing the recurrence rate (RR = 0.45; 95% CI: 0.07–3.10, ) and acid reflux (RR: 0.76, 95% CI: 0.47–1.23, ). Our findings show that XCHT can treat peptic ulcers as part of an alternative medicine approach.
1 March 2016 in China Journal of Chinese Materia Medica
In order to understand the characteristics of traditional Chinese medicine(TCM) syndrome types, the typical symptoms of different patients and the analysis of professor MA's medication characteristics of the treatment for infertility patients were analyzed. Totally 40 cases of infertile women treated in Xiyuan hospital and TCM out-patient department of China Academy of Chinese Medical Sciences in the past five years were randomly selected to classify their symptoms, signs and the four diagnostic situations in the first diagnosis, summarize syndromes and typical symptoms and analyze the characteristics of medication with Ma. Randomly selected nearly five years in 40 cases of infertile women with China Academy of Chinese Medical Sciences Xiyuan hospital and Chinese medicine out-patient department treatment, first diagnosed by symptoms, signs and the four diagnostic situation. According to the results, kidney yang deficiency: 10 cases (25%), kidney yin deficiency: 6 cases (15%), phlegm dampness: 3 cases (7.5%), liver qi stagnation: 3 cases (7.5%), blood stasis in the uterus: 7 cases (17.5%), deficiency of kidney yin deficiency and phlegm dampness: 1 cases (2.5%), kidney yin deficiency syndrome of liver qi stagnation: 2 cases (accounted for 5%), deficiency of kidney yang deficiency syndrome of liver qi stagnation: 1 cases (2.5%), phlegm dampness syndrome of liver qi stagnation:1 cases (2.5%), kidney yin deficiency syndrome, blood stasis and stagnation in the uterus 2 cases (accounted for 5%), liver qi stagnation syndrome and blood stasis in the uterus 2 cases (accounted for 5%), deficiency of kidney yang deficiency syndrome of liver qi stagnation syndrome and blood stasis in the uterus, 1 cases (2.5%). Typical symptoms were dominated by backache, pain and cold in the lower abdomen, followed by thirst, dry throat, more menstrual blood clots, more petechial hemorrhages at tongue, dysphoria, premenstrual breast pain, irritability, chest distress and greasy in mouth, leucorrhea, semiliquid stool or coprostasis. 40 cases of infertility patients showed obvious curative effect after the treatment of professor Ma's medication.